The SOCS1-low/SOCS3-high group represented about 15% of SOCS1-low HCC cases (Supplementary Figure S4b) and showed a significantly elevated CDKN1A expression compared to the SOCS1-low/SOCS3-low group (Figure 4a). This evidence concerns the gene SOCS1 and hepatocellular carcinoma.